Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (12)
  • Open Access

    ARTICLE

    Alisol A Exerts Anti-Proliferative Activity against Human Oral Cancer Cells through Triggering JNK/p38 MAPK-Mediated Apoptotic Cascade

    Yi-Tzu Chen1,2,3,#, Shao-Hsuan Kao4,5,#, Chun-Yi Chuang6,7, Chun-Wen Su4,5, Wei-En Yang4,5, Chih-Hsin Tang8,9,10, Shun-Fa Yang4,5,*, Chiao-Wen Lin2,3,*

    Oncology Research, Vol.33, No.11, pp. 3387-3404, 2025, DOI:10.32604/or.2025.069877 - 22 October 2025

    Abstract Background: Alisol A is a natural compound isolated from Alismatis Rhizoma, known for its diverse pharmacological activities, including anticancer and neuroprotective effects. This study aimed to explore the anticancer effects of Alisol A on oral cancer cells and elucidate its underlying mechanisms. Methods: Cell viability was measured by MTT assay, cell cycle by flow cytometry, and apoptosis by Annexin V/PI staining and caspase activation. Regulation of signaling pathways was analyzed using an apoptosis-related protein array, immunoblotting, and specific kinase inhibitors. Results: Alisol A reduced the viability of oral cancer cell lines, induced sub-G1 phase accumulation, and augmented… More >

  • Open Access

    ARTICLE

    Anticancer effects of SH003 and its active component Cucurbitacin D on oral cancer cell lines via modulation of EMT and cell viability

    HYEONG SIM CHOI1, JEONG-KUI KU1, SEONG-GYU KO2, PIL-YOUNG YUN1,3,*

    Oncology Research, Vol.33, No.5, pp. 1217-1227, 2025, DOI:10.32604/or.2025.059791 - 18 April 2025

    Abstract Background: Oral cancer remains a significant global health challenge, as it has high morbidity and mortality rates. Current treatments show limited efficacy and have severe side effects, prompting searches for new therapeutic agents. SH003, a traditional herbal formulation comprising Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii, has demonstrated potential anticancer properties in previous studies. However, its specific efficacy against oral cancer and the role of its key components, particularly Cucurbitacin D, remain underexplored. Methods: The cytotoxic effects of SH003 and its major components—i.e., Cucurbitacin D, Decursin, Formononetin, and Nodakenin—were evaluated using 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT), Trypan Blue exclusion, and… More >

  • Open Access

    ARTICLE

    Exosomal microRNA let-7c-5p enhances cell malignant characteristics by inhibiting TAGLN in oral cancer

    YI LI1, TIANYI WANG1, HAORAN DING1, SHIYONG ZHUANG1, XIAOBO DAI1, BING YAN1,2,*

    Oncology Research, Vol.32, No.10, pp. 1623-1635, 2024, DOI:10.32604/or.2024.048191 - 18 September 2024

    Abstract Background: Oral cancer, a malignancy that is prevalent worldwide, is often diagnosed at an advanced stage. MicroRNAs (miRNAs) in circulating exosomes have emerged as promising cancer biomarkers. The role of miRNA let-7c-5p in oral cancer remains underexplored, and its potential involvement in tumorigenesis warrants comprehensive investigation. Methods: Serum samples from 30 patients with oral cancer and 20 healthy controls were used to isolate exosomes and quantify their RNA content. Isolation of the exosomes was confirmed through transmission electron microscopy. Quantitative PCR was used to assess the miRNA profiles. The effects of let-7c-5p and TAGLN overexpression… More >

  • Open Access

    ARTICLE

    Paclitaxel induces human KOSC3 oral cancer cell apoptosis through caspase pathways

    YU-YAN LAN1,#, TSUN-CHIH CHENG2,#, YI-PING LEE3, CHIA-YIH WANG3,*, BU-MIIN HUANG3,4,*

    BIOCELL, Vol.48, No.7, pp. 1047-1054, 2024, DOI:10.32604/biocell.2024.050701 - 03 July 2024

    Abstract Background: Paclitaxel is a compound derived from Pacific yew bark that induces various cancer cell apoptosis. However, whether it also has anticancer activities in KOSC3 cells, an oral cancer cell line, is unclear. Methods: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, flow cytometry, and western blotting assays were carried out to assess cell viability, subG1 phase of the cell cycle, and apoptosis-related protein expression, respectively. Results: Our findings indicate that paclitaxel could inhibit cell viability and increase the expression of apoptotic markers, including plasma membrane blebbing and the cleavage of poly ADP-ribose polymerase in KOSC3 cells. Also, the treatment with paclitaxel More > Graphic Abstract

    Paclitaxel induces human KOSC3 oral cancer cell apoptosis through caspase pathways

  • Open Access

    ARTICLE

    Sailfish Optimization with Deep Learning Based Oral Cancer Classification Model

    Mesfer Al Duhayyim1,*, Areej A. Malibari2, Sami Dhahbi3, Mohamed K. Nour4, Isra Al-Turaiki5, Marwa Obayya6, Abdullah Mohamed7

    Computer Systems Science and Engineering, Vol.45, No.1, pp. 753-767, 2023, DOI:10.32604/csse.2023.030556 - 16 August 2022

    Abstract Recently, computer aided diagnosis (CAD) model becomes an effective tool for decision making in healthcare sector. The advances in computer vision and artificial intelligence (AI) techniques have resulted in the effective design of CAD models, which enables to detection of the existence of diseases using various imaging modalities. Oral cancer (OC) has commonly occurred in head and neck globally. Earlier identification of OC enables to improve survival rate and reduce mortality rate. Therefore, the design of CAD model for OC detection and classification becomes essential. Therefore, this study introduces a novel Computer Aided Diagnosis for… More >

  • Open Access

    ARTICLE

    Hyperparameter Tuning Bidirectional Gated Recurrent Unit Model for Oral Cancer Classification

    K. Shankar1, E. Laxmi Lydia2, Sachin Kumar1,*, Ali S. Abosinne3, Ahmed alkhayyat4, A. H. Abbas5, Sarmad Nozad Mahmood6

    CMC-Computers, Materials & Continua, Vol.73, No.3, pp. 4541-4557, 2022, DOI:10.32604/cmc.2022.031247 - 28 July 2022

    Abstract Oral Squamous Cell Carcinoma (OSCC) is a type of Head and Neck Squamous Cell Carcinoma (HNSCC) and it should be diagnosed at early stages to accomplish efficient treatment, increase the survival rate, and reduce death rate. Histopathological imaging is a wide-spread standard used for OSCC detection. However, it is a cumbersome process and demands expert’s knowledge. So, there is a need exists for automated detection of OSCC using Artificial Intelligence (AI) and Computer Vision (CV) technologies. In this background, the current research article introduces Improved Slime Mould Algorithm with Artificial Intelligence Driven Oral Cancer Classification… More >

  • Open Access

    ARTICLE

    Deep Transfer Learning Driven Oral Cancer Detection and Classification Model

    Radwa Marzouk1, Eatedal Alabdulkreem2, Sami Dhahbi3, Mohamed K. Nour4, Mesfer Al Duhayyim5, Mahmoud Othman6, Manar Ahmed Hamza7,*, Abdelwahed Motwakel7, Ishfaq Yaseen7, Mohammed Rizwanullah7

    CMC-Computers, Materials & Continua, Vol.73, No.2, pp. 3905-3920, 2022, DOI:10.32604/cmc.2022.029326 - 16 June 2022

    Abstract Oral cancer is the most commonly occurring ‘head and neck cancers’ across the globe. Most of the oral cancer cases are diagnosed at later stages due to absence of awareness among public. Since earlier identification of disease is essential for improved outcomes, Artificial Intelligence (AI) and Machine Learning (ML) models are used in this regard. In this background, the current study introduces Artificial Intelligence with Deep Transfer Learning driven Oral Cancer detection and Classification Model (AIDTL-OCCM). The primary goal of the proposed AIDTL-OCCM model is to diagnose oral cancer using AI and image processing techniques.… More >

  • Open Access

    REVIEW

    Translational aspects of the modern genetics in head and neck cancers

    FRANCESCO PADUANO1,2,*, EMANUELA ALTOMARE2,3, BENEDETTA MARRELLI1, VINCENZO DATTILO4, HAIZAL MOHD HUSSAINI5, PAUL ROY COOPER5, MARCO TATULLO6

    BIOCELL, Vol.46, No.8, pp. 1827-1835, 2022, DOI:10.32604/biocell.2022.020462 - 22 April 2022

    Abstract Oral Cancer (OC) is one of the most recurrent cancers in the head and neck squamous cancer (SCCHN) category. Recently, the genome-wide association studies (GWAS) have gained growing interest in the scientific community. GWAS have identified several pathways involved in the interactions among general risk factors and genomic variants affecting SCCHN. This systematic overview aims to critically evaluate the latest data reported within the scientific literature. The aim was to investigate the impact of genetic aspects on SCCHN onset and prognosis, involving other clinical and systemic co-factors. PubMed, Google Scholar, and Cancer Genetics Web databases More >

  • Open Access

    REVIEW

    The role of YAP in the control of the metastatic potential of oral cancer

    USAMA SHARIF AHMAD, KARTHIK SARAVANAN, HONG WAN*

    Oncology Research, Vol.29, No.6, pp. 377-391, 2021, DOI:10.32604/or.2022.026085 - 10 November 2022

    Abstract The Yes-associated protein (YAP) is a downstream effector of the Hippo pathway and acts as a key transcription co-factor to regulate cell migration, proliferation, and survival. The Hippo pathway is evolutionarily conserved and controls tissue growth and organ size. Dysregulation and heterogeneity of this pathway are found in cancers, including oral squamous cell carcinoma (OSCC), leading to overexpression of YAP and its regulated proliferation machinery. The activity of YAP is associated with its nuclear expression and is negatively regulated by the Hippo kinase-mediated phosphorylation resulting in an induction of its cytoplasmic translocation. This review focuses More >

  • Open Access

    ARTICLE

    DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells

    Naoki Katase*†, Shin-Ichiro Nishimatsu†‡, Akira Yamauchi§, Masahiro Yamamura, Kumiko Terada†‡, Masumi Itadani§, Naoko Okada¶#, Nur Mohammad Monsur Hassan**, Hitoshi Nagatsuka††, Tohru Ikeda*‡‡, Tsutomu Nohno, Shuichi Fujita*

    Oncology Research, Vol.26, No.1, pp. 45-58, 2018, DOI:10.3727/096504017X14926874596386

    Abstract DKK3, a member of the dickkopf Wnt signaling pathway inhibitor family, is believed to be a tumor suppressor because of its reduced expression in cancer cells. However, our previous studies have revealed that DKK3 expression is predominantly observed in head and neck/oral squamous cell carcinoma (HNSCC/OSCC). Interestingly, HNSCC/OSCC patients with DKK3 expression showed a high rate of metastasis and poorer survival, and siRNA-mediated knockdown of DKK3 in HNSCC-derived cancer cell lines resulted in reduced cellular migration and invasion. From these data, it was hypothesized that DKK3 might exert an oncogenic function specific to HNSCC. In… More >

Displaying 1-10 on page 1 of 12. Per Page